Possibility of lanthanum absorption in the stomach

Clinical Kidney Journal

Volumn 8, Issue 5, 2015, Pages 572-575

  Tonooka, Akiko ^a   Uda, Susumu ^a   Tanaka, Hiroki ^a   Yao, Atsushi ^a   Uekusa, Toshimasa ^a  

^a KANTO ROSAI HOSPITAL   (Japan)

Author keywords

Absorption; Dialysis; Lanthanum; Lymph node; Stomach

Indexed keywords

LANTHANUM CARBONATE;

AGED; ARTICLE; CANCER SIZE; CASE REPORT; DIABETIC NEPHROPATHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG TISSUE LEVEL; DRUG TRANSPORT; ENERGY DISPERSIVE X RAY SPECTROSCOPY; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LAMINA PROPRIA; LYMPH FLOW; LYMPH NODE; MACROPHAGE; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; STOMACH ABSORPTION; STOMACH ADENOCARCINOMA; TRANSMISSION ELECTRON MICROSCOPY; VERY ELDERLY;

EID: 84954041863     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv062     Document Type: Article

References (10)

1. Lacour B, Lucas A, Auchère D et al. Chronic renal failure is associated with increased tissue deposition of lanthanumafter 28-day oral administration. Kidney Int 2005;67:1062-1069
2. Pennick M, Dennis K, Damment SJ. Absolute bioavailability and disposition of lanthanumin healthy human subjects administered lanthanum carbonate. J Clin Pharmacol 2006;46:738-746
3. Zhang C, Wen J, Li Z et al. Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review. BMCNephrol 2013;14:226
4. Makino M, Kawaguchi K, Shimojo H et al. Extensive lanthanum deposition in the gastric mucosa: the first histopathological report. Pathol Int 2015;65:33-37
5. Haratake J, Yasunaga C, Ootani A et al. Peculiar histiocytic lesions with massive lanthanum deposition in dialysis patients treated with lanthanum carbonate. Am J Surg Pathol 2015;39:767-771
6. Shigematsu T, The Lanthanum Carbonate Research Group. Three-year extension study of lanthanumcarbonate therapy in Japanese hemodialysis patients. Clin Exp Nephrol 2010;14:589-597
7. Davis RL, Abraham JL. Lanthanum deposition in a dialysis patient. Nephrol Dial Transplant 2009;24:3247-3250
8. Spasovski GB, Sikole A, Gelev S et al. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant 2006;21:2217-2224
9. Damment SJ, Pennick M. Clinical pharmacokinetics of the phosphate binder lanthanum carbonate. Clin Pharmacokinet 2008;47:553-563
10. Iravani O, Tay BW, Chua PJ et al. Claudins and gastric carcinogenesis. Exp Biol Med 2013;238:344-349